Highlights and Quick Summary
- EBIT Growth for the quarter ending August 31, 2022 was 0.55 (a 172.22% increase compared to previous quarter)
- Year-over-year quarterly EBIT Growth increased by 12.57%
- Annual EBIT Growth for 2022 was 0.81 (a 132.94% increase from previous year)
- Annual EBIT Growth for 2021 was 0.35 (a -121.28% decrease from previous year)
- Annual EBIT Growth for 2020 was -1.64 (a -51.73% decrease from previous year)
- Twelve month EBIT Growth ending August 31, 2022 was 0.53 (a 5.88% increase compared to previous quarter)
- Twelve month trailing EBIT Growth increased by 1.63% year-over-year
Trailing EBIT Growth for the last four month:
| 31 Aug '22 | 31 May '22 | 28 Feb '22 | 30 Nov '21 |
|---|---|---|---|
| 0.53 | 0.5 | 0.69 | 0.52 |
Visit stockrow.com/OGI
for comprehensive keystats, realtime prices, income statement, balance sheet, cash flow
statement with 10 years of data, and state-of-the-art screener.
Historical EBIT Growth of Organigram Holdings Inc.
Most recent EBIT Growthof OGI including historical data for past 10 years.Interactive Chart of EBIT Growth of Organigram Holdings Inc.
Organigram Holdings Inc. EBIT Growth for the past 10 Years (both Annual and Quarterly)
| Year | Q1 | Q2 | Q3 | Q4 | Fiscal Year |
|---|---|---|---|---|---|
| 2022 | 0.55 | 0.2 | 0.69 | – | 0.81 |
| 2021 | 0.49 | 0.47 | 0.86 | -6.52 | 0.35 |
| 2020 | -184.93 | -0.6 | -7.44 | -1.3 | -1.64 |
| 2019 | -1.0 | -9.53 | 0.88 | 0.57 | -3.39 |
| 2018 | – | – | 302.44 | 1.12 | -17.17 |
| 2016 | – | – | – | – | 1.06 |
Business Profile of Organigram Holdings Inc.
Sector: Healthcare
Industry: Drug Manufacturers Specialty & Generic